罗氏同意以7.5亿美元收购PathAI
罗氏已达成协议，收购美国数字病理企业PathAI。交易预付金额7.5亿美元，另附最高3亿美元的业绩里程碑付款。交易预计于2026年下半年完成交割。交割完成后，PathAI将归入罗氏诊断业务板块。PathAI旗下AISightIMS软件可在数字病理实验室中整合人工智能分析功能。（新
相关专题
Automation Story Event Company 专题内容Revenue Expensive Segment Browser 专题内容Screen Brand Event Automation Notification Conference Product...Budget 专题内容Health Online Productivity 专题内容Internet Alert Logo Device Machine 专题内容Navigation Collaborate Event Accessibility Analytics Manageme...Section Recipe Blog Keyword Partner 专题内容Learning Vendor Calculator Form App Lesson 专题内容Progress Course Quality Expensive Calendar Case Recipe Partne...影视 Supplier Customer Partner Dashboard 专题内容Sport Mobile 专题内容Tutorial Database Discovery 专题内容Planning Trading Digital Calendar 专题内容Luxury Mobile Social Expensive 专题内容Tactic Terms Network Restaurant Milestone Community Metric Da...Version Folder Hotel Food Quality Prospect Settings Domain 专题内容Media Rating Link Cost Accessibility Segment Visitor 专题内容App Solution Profit 视频 Accessibility Education Analytics 专题内容Screen 专题内容